10 20 30 40 50 60 70 80 2W5U - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric Unit
HEADER ELECTRON TRANSPORT 12-DEC-08 2W5U
TITLE FLAVODOXIN FROM HELICOBACTER PYLORI IN COMPLEX WITH THE C3 INHIBITOR
COMPND MOL_ID: 1; COMPND 2 MOLECULE: FLAVODOXIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HELICOBACTER PYLORI; SOURCE 3 ORGANISM_TAXID: 210; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28A-FLDA
KEYWDS DRUG DISCOVERY, ELECTRON TRANSPORT, PROTEIN HINHIBITOR, FMN, KEYWDS 2 TRANSPORT, FLAVODOXIN, FLAVOPROTEIN
EXPDTA X-RAY DIFFRACTION
AUTHOR N.CREMADES,I.PEREZ-DORADO,J.A.HERMOSO,M.MARTINEZ-JULVEZ,J.SANCHO
REVDAT 3 05-JUL-17 2W5U 1 REMARK REVDAT 2 14-JUN-17 2W5U 1 LINK REVDAT 1 22-DEC-09 2W5U 0
JRNL AUTH N.CREMADES,A.VELAZQUEZ-CAMPOY,M.MARTINEZ-JULVEZ,J.L.NEIRA, JRNL AUTH 2 I.PEREZ-DORADO,J.HERMOSO,P.JIMENEZ,A.LANAS,P.S.HOFFMAN, JRNL AUTH 3 J.SANCHO JRNL TITL DISCOVERY OF SPECIFIC FLAVODOXIN INHIBITORS AS POTENTIAL JRNL TITL 2 THERAPEUTIC AGENTS AGAINST HELICOBACTER PYLORI INFECTION. JRNL REF ACS CHEM.BIOL. V. 4 928 2009 JRNL REFN ISSN 1554-8929 JRNL PMID 19725577 JRNL DOI 10.1021/CB900166Q
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.MARTINEZ-JULVEZ,N.CREMADES,M.BUENO,I.PEREZ-DORADO,C.MAYA, REMARK 1 AUTH 2 S.CUESTA-LOPEZ,D.PRADA,F.FALO,J.A.HERMOSO,J.SANCHO REMARK 1 TITL COMMON CONFORMATIONAL CHANGES IN FLAVODOXINS INDUCED BY FMN REMARK 1 TITL 2 AND ANION BINDING: THE STRUCTURE OF HELICOBACTER PYLORI REMARK 1 TITL 3 APOFLAVODOXIN. REMARK 1 REF PROTEINS V. 69 581 2007 REMARK 1 REFN ISSN 0887-3585 REMARK 1 PMID 17623845 REMARK 1 DOI 10.1002/PROT.21410 REMARK 1 REFERENCE 2 REMARK 1 AUTH N.CREMADES,M.BUENO,M.TOJA,J.SANCHO REMARK 1 TITL TOWARDS A NEW THERAPEUTIC TARGET: HELICOBACTER PYLORI REMARK 1 TITL 2 FLAVODOXIN. REMARK 1 REF BIOPHYS.CHEM. V. 115 267 5 REMARK 1 REFN ISSN 0301-4622 REMARK 1 PMID 15752617 REMARK 1 DOI 10.1016/J.BPC.2004.12.045
REMARK 2 REMARK 2 RESOLUTION. 2.62 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 7928 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : 595 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.62 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2830 REMARK 3 BIN FREE R VALUE : 0.3060 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2446 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 83 REMARK 3 SOLVENT ATOMS : 89 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.37000 REMARK 3 B22 (A**2) : -0.34000 REMARK 3 B33 (A**2) : -2.19000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.55000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.580 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.772 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.430 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.053 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.117 ; 4.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: AFTER MODEL REFINEMENT WITH CNS PROGRAM REMARK 3 A LAST CYCLE OF REFINEMENT WAS PERFORMED USING REFMAC5 WITH TLS. REMARK 3 INITIAL METEONINE RESIDUE WAS NOT OBSERVED NEITHER IN MOLECULE A REMARK 3 NOR IN MOLECULE B
REMARK 4 REMARK 4 2W5U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-DEC-08. REMARK 100 THE DEPOSITION ID IS D_1290038318.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-MAY-08 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ENRAF-NONIUS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8523 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.620 REMARK 200 RESOLUTION RANGE LOW (A) : 22.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 6.000 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.26000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1FUE REMARK 200 REMARK 200 REMARK: NONE
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.48350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET B 1
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 44 CB OG REMARK 470 GLU A 124 CG CD OE1 OE2 REMARK 470 SER A 153 OG REMARK 470 SER B 44 CB OG REMARK 470 GLU B 124 CG CD OE1 OE2 REMARK 470 SER B 153 OG
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP B 11 CB - CG - OD2 ANGL. DEV. = 5.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 55 -169.11 -111.61 REMARK 500 THR A 62 -60.52 -29.67 REMARK 500 ASN A 78 20.05 -79.87 REMARK 500 LYS A 108 -9.69 -52.34 REMARK 500 SER A 126 120.85 -176.19 REMARK 500 ARG A 160 -57.65 -12.06 REMARK 500 VAL B 34 -9.07 -53.42 REMARK 500 THR B 62 -68.14 -28.98 REMARK 500 THR B 95 56.28 -147.38 REMARK 500 LYS B 108 -6.60 -55.27 REMARK 500 VAL B 135 3.98 -64.77 REMARK 500 PHE B 163 50.03 -117.78 REMARK 500 REMARK 500 REMARK: NULL
REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED.
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN B 165 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF RESIDUES 165 TO 166
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BMV RELATED DB: PDB REMARK 900 APOFLAVODOXIN FROM HELICOBACTER PYLORI
REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE CONFLICTS LISTED IN THE SEQADV RECORDS BELOW REMARK 999 ARE DUE TO THE FACT THAT THE PROTEIN SEQUENCE WAS OBTAINED REMARK 999 DIRECTLY FROM THE H.PYLORI BACTERIA OF A PATIENT.
DBREF 2W5U A 1 164 UNP O25776 FLAV_HELPY 1 164 DBREF 2W5U B 1 164 UNP O25776 FLAV_HELPY 1 164
SEQADV 2W5U ASN A 78 UNP O25776 THR 78 CONFLICT SEQADV 2W5U SER A 117 UNP O25776 PRO 117 CONFLICT SEQADV 2W5U ARG A 160 UNP O25776 LYS 160 CONFLICT SEQADV 2W5U ASN B 78 UNP O25776 THR 78 CONFLICT SEQADV 2W5U SER B 117 UNP O25776 PRO 117 CONFLICT SEQADV 2W5U ARG B 160 UNP O25776 LYS 160 CONFLICT
SEQRES 1 A 164 MET GLY LYS ILE GLY ILE PHE PHE GLY THR ASP SER GLY SEQRES 2 A 164 ASN ALA GLU ALA ILE ALA GLU LYS ILE SER LYS ALA ILE SEQRES 3 A 164 GLY ASN ALA GLU VAL VAL ASP VAL ALA LYS ALA SER LYS SEQRES 4 A 164 GLU GLN PHE ASN SER PHE THR LYS VAL ILE LEU VAL ALA SEQRES 5 A 164 PRO THR ALA GLY ALA GLY ASP LEU GLN THR ASP TRP GLU SEQRES 6 A 164 ASP PHE LEU GLY THR LEU GLU ALA SER ASP PHE ALA ASN SEQRES 7 A 164 LYS THR ILE GLY LEU VAL GLY LEU GLY ASP GLN ASP THR SEQRES 8 A 164 TYR SER GLU THR PHE ALA GLU GLY ILE PHE HIS ILE TYR SEQRES 9 A 164 GLU LYS ALA LYS ALA GLY LYS VAL VAL GLY GLN THR SER SEQRES 10 A 164 THR ASP GLY TYR HIS PHE GLU ALA SER LYS ALA VAL GLU SEQRES 11 A 164 GLY GLY LYS PHE VAL GLY LEU VAL ILE ASP GLU ASP ASN SEQRES 12 A 164 GLN ASP ASP LEU THR ASP GLU ARG ILE SER LYS TRP VAL SEQRES 13 A 164 GLU GLN VAL ARG GLY SER PHE ALA SEQRES 1 B 164 MET GLY LYS ILE GLY ILE PHE PHE GLY THR ASP SER GLY SEQRES 2 B 164 ASN ALA GLU ALA ILE ALA GLU LYS ILE SER LYS ALA ILE SEQRES 3 B 164 GLY ASN ALA GLU VAL VAL ASP VAL ALA LYS ALA SER LYS SEQRES 4 B 164 GLU GLN PHE ASN SER PHE THR LYS VAL ILE LEU VAL ALA SEQRES 5 B 164 PRO THR ALA GLY ALA GLY ASP LEU GLN THR ASP TRP GLU SEQRES 6 B 164 ASP PHE LEU GLY THR LEU GLU ALA SER ASP PHE ALA ASN SEQRES 7 B 164 LYS THR ILE GLY LEU VAL GLY LEU GLY ASP GLN ASP THR SEQRES 8 B 164 TYR SER GLU THR PHE ALA GLU GLY ILE PHE HIS ILE TYR SEQRES 9 B 164 GLU LYS ALA LYS ALA GLY LYS VAL VAL GLY GLN THR SER SEQRES 10 B 164 THR ASP GLY TYR HIS PHE GLU ALA SER LYS ALA VAL GLU SEQRES 11 B 164 GLY GLY LYS PHE VAL GLY LEU VAL ILE ASP GLU ASP ASN SEQRES 12 B 164 GLN ASP ASP LEU THR ASP GLU ARG ILE SER LYS TRP VAL SEQRES 13 B 164 GLU GLN VAL ARG GLY SER PHE ALA
HET FMN A 165 31 HET IC3 A 166 21 HET FMN B 165 31
HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM IC3 [2-(5-AMINO-4-CYANO-1H-PYRAZOL-1-YL)-5- HETNAM 2 IC3 (TRIFLUOROMETHYL)PHENYL](HYDROXY)OXOAMMONIUM
HETSYN FMN RIBOFLAVIN MONOPHOSPHATE
FORMUL 3 FMN 2(C17 H21 N4 O9 P) FORMUL 4 IC3 C11 H7 F3 N5 O2 1+ FORMUL 6 HOH *89(H2 O)
HELIX 1 1 GLY A 13 GLY A 27 1 15 HELIX 2 2 ALA A 35 ALA A 37 5 3 HELIX 3 3 SER A 38 ASN A 43 1 6 HELIX 4 4 GLY A 56 GLY A 58 5 3 HELIX 5 5 GLN A 61 THR A 70 1 10 HELIX 6 6 GLU A 72 ALA A 77 1 6 HELIX 7 7 GLU A 98 LYS A 108 1 11 HELIX 8 8 ASP A 140 ASP A 145 1 6 HELIX 9 9 LEU A 147 GLY A 161 1 15 HELIX 10 10 GLY B 13 GLY B 27 1 15 HELIX 11 11 SER B 38 ASN B 43 1 6 HELIX 12 12 GLY B 56 GLY B 58 5 3 HELIX 13 13 GLN B 61 THR B 70 1 10 HELIX 14 14 ALA B 73 ASN B 78 1 6 HELIX 15 15 GLY B 99 LYS B 108 1 10 HELIX 16 16 GLN B 144 ASP B 146 5 3 HELIX 17 17 LEU B 147 GLY B 161 1 15
SHEET 1 AA 5 ALA A 29 ASP A 33 0 SHEET 2 AA 5 ILE A 4 PHE A 8 1 O ILE A 4 N GLU A 30 SHEET 3 AA 5 LYS A 47 ALA A 52 1 O LYS A 47 N GLY A 5 SHEET 4 AA 5 THR A 80 LEU A 86 1 O THR A 80 N VAL A 48 SHEET 5 AA 5 LEU A 137 ILE A 139 -1 O LEU A 137 N GLY A 85 SHEET 1 AB 5 ALA A 29 ASP A 33 0 SHEET 2 AB 5 ILE A 4 PHE A 8 1 O ILE A 4 N GLU A 30 SHEET 3 AB 5 LYS A 47 ALA A 52 1 O LYS A 47 N GLY A 5 SHEET 4 AB 5 THR A 80 LEU A 86 1 O THR A 80 N VAL A 48 SHEET 5 AB 5 LYS A 111 VAL A 113 1 O LYS A 111 N ILE A 81 SHEET 1 AC 2 LEU A 137 ILE A 139 0 SHEET 2 AC 2 THR A 80 LEU A 86 -1 O LEU A 83 N LEU A 137 SHEET 1 AD 2 THR A 54 ALA A 55 0 SHEET 2 AD 2 ASP A 59 LEU A 60 -1 O ASP A 59 N ALA A 55 SHEET 1 AE 2 VAL A 129 GLU A 130 0 SHEET 2 AE 2 LYS A 133 PHE A 134 -1 O LYS A 133 N GLU A 130 SHEET 1 BA 5 ALA B 29 ASP B 33 0 SHEET 2 BA 5 ILE B 4 PHE B 8 1 O ILE B 4 N GLU B 30 SHEET 3 BA 5 LYS B 47 ALA B 52 1 O LYS B 47 N GLY B 5 SHEET 4 BA 5 THR B 80 LEU B 86 1 O THR B 80 N VAL B 48 SHEET 5 BA 5 LEU B 137 ILE B 139 -1 O LEU B 137 N GLY B 85 SHEET 1 BB 5 ALA B 29 ASP B 33 0 SHEET 2 BB 5 ILE B 4 PHE B 8 1 O ILE B 4 N GLU B 30 SHEET 3 BB 5 LYS B 47 ALA B 52 1 O LYS B 47 N GLY B 5 SHEET 4 BB 5 THR B 80 LEU B 86 1 O THR B 80 N VAL B 48 SHEET 5 BB 5 LYS B 111 VAL B 112 1 O LYS B 111 N ILE B 81 SHEET 1 BC 2 LEU B 137 ILE B 139 0 SHEET 2 BC 2 THR B 80 LEU B 86 -1 O LEU B 83 N LEU B 137 SHEET 1 BD 2 THR B 54 ALA B 55 0 SHEET 2 BD 2 ASP B 59 LEU B 60 -1 O ASP B 59 N ALA B 55 SHEET 1 BE 2 VAL B 129 GLU B 130 0 SHEET 2 BE 2 LYS B 133 PHE B 134 -1 O LYS B 133 N GLU B 130
SITE 1 AC1 20 THR B 10 ASP B 11 SER B 12 GLY B 13 SITE 2 AC1 20 ASN B 14 ALA B 15 PRO B 53 THR B 54 SITE 3 AC1 20 ALA B 55 GLY B 56 GLY B 58 LEU B 86 SITE 4 AC1 20 GLY B 87 ASP B 88 TYR B 92 THR B 95 SITE 5 AC1 20 PHE B 96 ALA B 97 ASP B 142 HOH B2012 SITE 1 AC2 22 THR A 10 ASP A 11 SER A 12 GLY A 13 SITE 2 AC2 22 ASN A 14 ALA A 15 PRO A 53 THR A 54 SITE 3 AC2 22 ALA A 55 GLY A 56 ALA A 57 GLY A 58 SITE 4 AC2 22 LEU A 86 GLY A 87 ASP A 88 TYR A 92 SITE 5 AC2 22 THR A 95 PHE A 96 ALA A 97 ASP A 142 SITE 6 AC2 22 ALA A 164 HOH A2048
CRYST1 38.533 50.967 72.806 90.00 98.64 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.025952 0.000000 0.003943 0.00000
SCALE2 0.000000 0.019621 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013893 0.00000
MTRIX1 1 -0.955900 -0.010500 -0.293600 42.85780 1
MTRIX2 1 0.009500 -0.999900 0.004600 1.23550 1
MTRIX3 1 -0.293700 0.001600 0.955900 -30.39470 1